Metabolic Lab Migraine Evaluation: Understanding Causes

Using Internal Medicine and Lifestyle Evaluation to Address Contributors Across Migraine, Stress, and Vascular Patterns

Sarah had been living with headaches for nearly four years. Some days the pain started behind her eyes after a short night of sleep. On others, it arrived in the afternoon when she skipped lunch or felt unusually stressed. Over-the-counter pain medicine helped for a while, then stopped working. She began to wonder whether the problem was “just migraine,” something hormonal, or a mix of both. When she came to the clinic, the first step was not another prescription. It was a careful look at the coexisting patterns that can make a diagnosed headache disorder more frequent and harder to control.

Frequent headaches rarely exist in isolation. Sleep quality, medication use, hormone shifts, and metabolic factors often interact with the neurological processes that drive migraine. Stress can tighten neck and shoulder muscles and raise inflammatory signals. Vascular patterns may change with blood-sugar swings or hormonal fluctuations. Addressing these contributors through internal medicine and lifestyle evaluation gives patients a clearer picture of what is aggravating their headaches and what can be improved alongside structural and rehabilitative care.

When Sleep, Medication Patterns, Hormones, and Metabolism Amplify Headache Frequency

Many people with migraines notice that poor sleep makes the next day harder. Interrupted or insufficient sleep can lower the threshold for a headache to begin. At the same time, some patients start taking pain relievers more often. When medication is used more than two or three days per week for an extended period, it can contribute to medication-overuse headache. The original migraine pattern remains, yet the frequent medicine use adds another layer of daily pain.

Hormonal changes are another common influence. For some women, headaches cluster around menstrual cycles or intensify during perimenopause. Thyroid function can also play a role; even mild shifts may affect energy, sleep, and headache frequency. Metabolic factors matter as well. Blood-sugar variability, insulin resistance, and low-grade inflammation can make the nervous system more reactive. A patient who notices headaches after missed meals or late-afternoon energy crashes often has metabolic contributors that laboratory testing can help clarify.

These factors do not replace a proper headache diagnosis. They sit alongside it. Recognizing them lets the care team address the full pattern, not just the immediate pain.

Lab-Supported Assessment of Coexisting Conditions

Under the medical direction of Dr. Maria Guadalupe Cardenas, MD, selected laboratory testing can identify modifiable contributors that aggravate diagnosed headache disorders. Testing is chosen based on the individual’s history and examination, not a single routine panel. Common areas of evaluation include:

• Inflammatory and metabolic markers such as high-sensitivity C-reactive protein, fasting glucose, hemoglobin A1c, and a standard metabolic panel. These help show whether low-grade inflammation or blood-sugar dysregulation is present.
• Hormonal and thyroid assessment, including TSH, free T4, and, when clinically indicated, other relevant markers. These results help distinguish pure migraine patterns from those influenced by endocrine shifts.
• Nutrient status, such as vitamin D, ferritin, vitamin B12, and magnesium. Deficiencies in these areas have been associated with higher headache frequency in clinical literature and can be corrected with targeted support.
• Additional metabolic or organic-acid insights when fatigue, brain fog, or digestive symptoms coexist with the headaches.

Results are interpreted in a clinical context. An elevated inflammatory marker does not prove inflammation is the sole cause of a person’s migraine, but it can guide practical steps such as nutrition changes, sleep improvement, and reducing medication overuse. The same results are shared directly with the patient so decisions remain informed.

These laboratory findings are then coordinated with the soft-tissue and rehabilitative evaluation performed by Dr. Alex Jimenez, DC, APRN, FNP-BC. We document cervical range of motion, muscle tension patterns, and functional movement alongside the lab data. Together, they show how systemic contributors and structural factors may interact.

For a broader view of how laboratory assessment fits into comprehensive migraine pathways, see the integrated clinical guide at https://dralexjimenez.com/integrated-migraine-treatment-el-paso-complete-clinical-guide/.

Integrating Medical Oversight with Rehabilitative and Preventive Care

Once coexisting contributors are clearer, care can be matched more precisely. Lifestyle measures often form the foundation. Consistent sleep timing, regular meals that stabilize blood sugar, and gradually reducing frequent pain-reliever use are practical steps many patients can start immediately. Chiropractic adjustments, targeted soft-tissue work, and, when appropriate, neurofunctional acupuncture or electroacupuncture address stress-related muscle tension. These approaches support mobility and reduce peripheral sensitization without adding another daily medication.

When a patient meets established criteria for chronic migraine—headaches on 15 or more days per month with migraine features on at least eight of those days—guideline-based preventive options such as onabotulinumtoxinA can be considered under medical oversight. The laboratory and lifestyle evaluation does not replace those criteria; it helps ensure other aggravating factors are being addressed at the same time. Details on current clinical guidelines for this approach appear in the 2026 Botox chronic migraine guide at https://dralexjimenez.com/?p=382207.

The goal is to provide coordinated, not fragmented, care. Dr. Cardenas provides medical direction and the laboratory and internal-medicine framework. Soft-tissue and functional evaluation from Dr. Jimenez supplies the structural and rehabilitative layer. Patients see both the systemic and the musculoskeletal pieces of the same picture.

What Makes This Approach Unique in El Paso

Injury Medical Clinic PA is one of the only clinics in El Paso, Texas, that combines a board-certified internal medicine medical director with a dual-licensed nurse practitioner specializing in soft-tissue injury. Dr. Maria Guadalupe Cardenas, MD, serves as Medical Director and oversees complex metabolic, hormonal, and inflammatory patterns. Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, brings both chiropractic and advanced practice nursing expertise focused on soft-tissue injury, functional testing, and rehabilitative care. Together, they offer laboratory-supported evaluation and non-pharmacologic options under one coordinated team—an arrangement not commonly available elsewhere in the region.

Bioethical Foundations That Guide the Process

Beneficence guides the emphasis on root-cause support. Identifying and addressing sleep, metabolic, hormonal, and medication-overuse contributors aims to reduce headache frequency and improve daily function rather than simply masking symptoms. Non-maleficence is reflected in the preference for non-invasive, drug-sparing strategies whenever they are appropriate. Lifestyle adjustments, targeted nutrition, chiropractic care, and acupuncture reduce the risk of accumulating multiple medications and their side effects. Autonomy is protected by sharing laboratory results, headache-diary data, and clinical findings directly with the patient. Individuals remain the informed decision-makers who choose how to incorporate this information into their care plan and coordinate with other providers.

These objective markers—laboratory values, timed headache diaries, and functional findings—support comprehensive pathways detailed at https://dralexjimenez.com.

Patients who recognize their pattern in the descriptions above can begin with a focused evaluation that includes both internal-medicine laboratory assessment and soft-tissue examination. The resulting plan is tailored, measurable, and coordinated so that medical, lifestyle, and rehabilitative elements work together.

References

Headache Classification Committee of the International Headache Society (IHS). (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38(1), 1–211. https://doi.org/10.1177/0333102417738202

Dodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H. C., & Brin, M. F. (2010). OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache, 50(6), 921–936. https://doi.org/10.1111/j.1526-4610.2010.01678.x

Aurora, S. K., Dodick, D. W., Turkel, C. C., DeGryse, R. E., Silberstein, S. D., Lipton, R. B., Diener, H. C., & Brin, M. F. (2010). OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia, 30(7), 793–803. https://doi.org/10.1177/0333102410364676

Diener, H. C., Dodick, D. W., Aurora, S. K., Turkel, C. C., DeGryse, R. E., Lipton, R. B., Silberstein, S. D., & Brin, M. F. (2010). OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia, 30(7), 804–814. https://doi.org/10.1177/0333102410364677

American Academy of Neurology & American Headache Society. (2025). Pharmacologic treatment for migraine prevention in adults: Practice guideline recommendations. Neurology. Advance online publication. https://www.neurology.org/doi/10.1212/WNL.0000000000214881

Metabolic Dysfunction and Dietary Interventions in Migraine Management: The Role of Insulin Resistance and Neuroinflammation—A Narrative and Scoping Review. (2025). Brain Sciences, 15(5), 474. https://doi.org/10.3390/brainsci15050474

Gosalia, H., Moreno-May, J., & Knievel, K. L. (2024). Medication-overuse headache: A narrative review. The Journal of Headache and Pain, 25, Article 89. https://doi.org/10.1186/s10194-024-01755-w

Tiseo, C., Vacca, A., Felbush, A., Filimonova, T., Gai, A., Glazyrina, T., Hubalek, I. A., Marchenko, Y., Overeem, L. H., Piroso, S., Tkachev, A., Martelletti, P., & Sacco, S. (2020). Migraine and sleep disorders: A systematic review. The Journal of Headache and Pain, 21, Article 126. https://doi.org/10.1186/s10194-020-01192-5

Holland, S., Silberstein, S. D., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012). Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology, 78(17), 1346–1353. https://doi.org/10.1212/WNL.0b013e3182535d0c

Nattagh-Eshtivani, E., Sani, M. A., Dahri, M., Ghalichi, F., Ghavami, A., Arjang, P., & Tarighat-Esfanjani, A. (2024). Effects of selected dietary supplements on migraine prophylaxis: A systematic review and dose–response meta-analysis of randomized controlled trials. Neurological Sciences, 46, 651–670. https://doi.org/10.1007/s10072-024-07794-0